Inclusion Criteria : 
  1.  TNM stage I - II ( T1 - 4 N0M0 ) colorectal cancer cases
  2.  receive radical surgical resection
  3.  have completed data of tumor location , histological type , behavioral characteristics or TNM staging
  4.  have tumor specimens and either a valid microsatellite instability ( MSI ) or immuno - histochemistry ( IHC ) data
  5.  have valid V - raf murine sarcoma viral oncogene homolog B1 ( BRAF )  , kirsten rat sarcoma viral oncogene ( KRAS )  , CpG island methylator phenotype ( CIMP ) results
  6.  have at least 4 years of follow - up
  7.  have valid time to local recurrence / metastasis in follow - up
  8.  have clinical / treatment record data and valid pre operative status of intestinal obstruction or perforation ( IOP )  , counts of lymph node removed in surgical resection . 
Exclusion Criteria : 
  1.  have had a previous diagnosis of any cancer or presence of any tumor other than the CRC
  2.  have had inflammatory bowel disease
  3.  have had hereditary colorectal cancer syndromes , including Familial adenomatous polyposis , mutyh ( MYH )  - associated polyposis , Peutz - Jeghers syndrome , Juvenile polyposis coli , phosphate and tension homology deleted on chromosome ten ( PTEN ) tumor - hamartoma syndromes , Lynch Syndrome , and Familial Colorectal Cancer Type X.